Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
OROS-Methylphenidate Titration in Children with ADHD
NCT00518232Phase 4Completed
- Sponsor
- Johnson & Johnson
- Start
- Sep 2006
- Primary completion
- Jun 2007
- Modality
- Small Molecules
01
Overview
A Phase 4 trial of methylphenidate in attention deficit hyperactivity disorder (ADHD), sponsored by Johnson & Johnson. Started Sep 2006; status: completed.
02
Drugs
methylphenidate
03
Conditions
attention deficit hyperactivity disorder (ADHD)
Beyond the preview
Go deeper on NCT00518232.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00518232.